Lir Life Sciences Corp.: LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP/GIP-based Obesity Therapies

VANCOUVER, BC / ACCESS Newswire / January 15, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790, WKN:A41QA9) ("LIR" or the "Company")is pleased to announce the launch of a contr ...
Nasdaq

atai Life Sciences Announces Positive Results from Phase 2a Study of BPL-003 for Treatment-Resistant Depression

Atai Life Sciences announced positive results from Beckley Psytech's Phase 2a study of BPL-003, an adjunctive treatment for patients with treatment-resistant depression (TRD) who are already on ...
Inc

Want to Live a Longer, Healthier, More Meaningful Life? Science Says People With Greater Resilience Enjoy Exceptional Longevity

According to a study published in BMJ Mental Health, compared to people with low levels of mental resilience, people with high levels of mental resilience — calmness, determination and perseverance, ...
Seeking Alpha

Wave Life Sciences Is A Buy On Pipeline Prospects

Wave Life Sciences develops stereopure oligonucleotides targeting genetic mutations, with lead assets in DMD, AATD, and Huntington's Disease showing promising data. Major collaborations with GSK and ...